What is Bendectin and why was it controversial?
Bendectin is an antinauseant medication formerly prescribed for morning sickness and withdrawn from the market in 1982. Controversy arose as registry and research data linked Bendectin use to increases in limb reduction defects, oral clefts, and diaphragmatic hernias in infants, stimulating debate over drug safety.
This antinauseant medication was removed from the world market in 1982. Registry data have found patterns of increases in limb reduction defects, oral clefts and diaphragmatic hernias. These findings are consistent with both animal and human studies.
For daily information about new research on birth defects, visit our 
